ASSESSMENT OF THE RISK ON ENDOMETRIAL CANCER IN HYPERPLASIA, BY MEANS OF MORPHOLOGICAL AND MORPHOMETRICAL FEATURES

被引:59
|
作者
BAAK, JPA
WISSEBREKELMANS, ECM
FLEEGE, JC
VANDERPUTTEN, HWHM
BEZEMER, PD
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT GYNECOL,1081 HV AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1081 HV AMSTERDAM,NETHERLANDS
关键词
ENDOMETRIUM; HYPERPLASIA; PROGNOSIS;
D O I
10.1016/S0344-0338(11)80244-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The value of two 'cancer risk " assessment rules (one consisting of qualitative microscopical features and one consisting of morphometric characteristics) bas been evaluated in 39 patients with hyperplasia of the endometrium. Of these, in seven (7139 = 18 %) cancer was detected in the follow-up and 32 remained stable or became less abnormal. The results of the qualitative analysis were well in agreement with those published earlier7. In none of the eight patients with simple hyperplasia cancer was detected, in contrast to five of the 11 patients (45 %) with cytologic atypia and glandular complexity. Twenty patients showed cytologic atypicality in the absence of glandular complexity, or no atypicality but glandular complexity; in two (1 0 %) of these patients cancer was detected later in the follow-up. The morphometric rule (consisting of volume percentage of stroma, log-normally transformed standard deviation of the shortest nuclear axis and outer surface density of the glands) results in a multivariate score. Nineteen patients bad a score value above 0.6 and in none of them cancer was found. In contrast, in seven of the 20 patients (35 %) with a score value below 0.6, cancer was detected. Regarding the question which of the techniques is more powerful the specificity is better with the qualitative evaluations; the sensitivity is higher with the morphometric rule. An advantage of the morphometric rule is that only two groups (very low/very high risk) are discerned.
引用
收藏
页码:856 / 859
页数:4
相关论文
共 50 条
  • [31] Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway
    Orbo, A
    Baak, JPA
    Kleivan, I
    Lysne, S
    Prytz, PS
    Broeckaert, MAM
    Slappendel, A
    Tichelaar, HJ
    JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (09) : 697 - 703
  • [32] Predicting risk of relapse in endometrial hyperplasia
    De Silva, P. M.
    Gallos, I. D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 (07) : 944 - 944
  • [33] Endometrial hyperplasia and the risk of progression to carcinoma
    Lacey, James V., Jr.
    Chia, Victoria M.
    MATURITAS, 2009, 63 (01) : 39 - 44
  • [34] EFFECT OF PROGESTATIONAL AGENT ON ENDOMETRIAL HYPERPLASIA + ENDOMETRIAL CANCER
    WENTZ, WB
    OBSTETRICS AND GYNECOLOGY, 1964, 24 (03): : 370 - &
  • [35] The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer
    Lai, Chyong-Huey
    Huang, Huei-Jean
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (01) : 29 - 34
  • [36] Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram
    Zhang, He
    Kong, Weimin
    Han, Chao
    Liu, Tingting
    Li, Jing
    Song, Dan
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7937 - 7949
  • [37] Risk of endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia treated with total laparoscopic hysterectomy
    Oda, Katsutoshi
    Koga, Kaori
    Hirata, Tetsuya
    Maruyama, Masanori
    Ikemura, Masako
    Matsumoto, Yoko
    Nagasaka, Kazunori
    Adachi, Katsuyuki
    Mori-Uchino, Mayuyo
    Sone, Kenbun
    Arimoto, Takahide
    Wada-Hiraike, Osamu
    Kawana, Kei
    Fukayama, Masashi
    Fujii, Tomoyuki
    Osuga, Yutaka
    GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT, 2016, 5 (02): : 69 - 73
  • [38] Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis
    Doherty, Michelle T.
    Sanni, Omolara B.
    Coleman, Helen G.
    Cardwell, Chris R.
    McCluggage, W. Glenn
    Quinn, Declan
    Wylie, James
    McMenamin, Una C.
    PLOS ONE, 2020, 15 (04):
  • [39] CONCURRENT AND FUTURE RISK OF ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Michelle, D.
    Sanni, O. B.
    Coleman, H. G.
    Cardwell, C. R.
    McCluggage, W. G.
    Quinn, D.
    Wylie, J.
    McMenamin, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A144 - A145
  • [40] RISK OF ENDOMETRIAL CARCINOMA AFTER THE DIAGNOSIS OF ATYPICAL ENDOMETRIAL HYPERPLASIA
    Prat, J.
    Szafranska, J.
    D'Angelo, E.
    Serrat, N.
    Barbareschi, M.
    Espinosa, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 247 - 247